Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$9.56 USD
-0.03 (-0.31%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $9.55 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
12/09/2024
Time: -- |
9/2024 | $-0.64 | 0.00% |
Earnings Summary
For their last quarter, Lexeo Therapeutics, Inc. (LXEO) reported earnings of -$0.64 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for LXEO's next earnings release expected on December 09, 2024. For the next earning release, we expect the company to report earnings of -$0.64 per share, reflecting a year-over-year increase of 94.82%.
Earnings History
Price & Consensus
Zacks News for LXEO
Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data
LXEO: What are Zacks experts saying now?
Zacks Private Portfolio Services